#BEGIN_DRUGCARD DB01768

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C21H25NO11

# Chemical_IUPAC_Name:
(2S,4R,5S,6S)-5-acetamido-4-hydroxy-2-[(4-methyl-2-oxo-2H-chromen-7-yl)oxy]-6-[(1S,2R)-1,2,3-trihydroxypropyl]oxane-2-carboxylic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
Methylumbelliferyl Sialic Acid

# HET_ID:
MUS

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C21H25NO11/c1-9-5-16(27)31-15-6-11(3-4-12(9)15)32-21(20(29)30)7-13(25)17(22-10(2)24)19(33-21)18(28)14(26)8-23/h3-6,13-14,17-19,23,25-26,28H,7-8H2,1-2H3,(H,22,24)(H,29,30)/t13-,14-,17+,18+,19+,21-/m1/s1

# InChI_Key:
InChIKey=KKDWIUJBUSOPGC-CJRKPKEDSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
1768

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
467.4233

# Molecular_Weight_Mono:
467.142760647

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1S0J

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-0.91

# Predicted_LogS:
-2.1

# Predicted_Water_Solubility:
3.88e+00 g/l

# Primary_Accession_No:
DB01768

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
46936209

# PubChem_Substance_ID:
46504808

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT02257

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
CC(=O)N[C@H]1[C@H](O)C[C@@](OC2=CC=C3C(C)=CC(=O)OC3=C2)(O[C@@H]1[C@@H](O)[C@H](O)CO)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:20:28 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cytoplasmic

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
Not Available

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
L26499

# Drug_Target_1_GenBank_ID_Protein:
Not Available

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
Not Available

# Drug_Target_1_Gene_Sequence:
>1929 bp
ATGCTGGCACCCGGATCGAGCCGAGTTGAGCTGTTTAAGCGGCAAAGCTCGAAGGTGCCA
TTTGAAAAGGACGGCAAAGTCACCGAGCGGGTTGTCCACTCGTTCCGCCTCCCCGCCCTT
GTTAATGTGGACGGGGTGATGGTTGCCATCGCGGACGCTCGCTACGAAACATCCAATGAC
AACTCCCTCATTGATACGGTGGCGAAGTACAGCGTGGACGATGGGGAGACGTGGGAGACC
CAAATTGCCATCAAGAACAGTCGTGCATCGTCTGTTTCTCGTGTGGTGGATCCCACAGTG
ATTGTGAAGGGCAACAAGCTTTACGTCCTGGTTGGAAGCTACAACAGTTCGAGGAGCTAC
TGGACGTCGCATGGTGATGCGAGAGACTGGGATATTCTGCTTGCCGTTGGTGAGGTCACG
AAGTCCACTGCGGGCGGCAAGATAACTGCGAGTATCAAATGGGGGAGCCCCGTGTCACTG
AAGGAATTTTTTCCGGCGGAAATGGAAGGAATGCACACAAATCAATTTCTTGGCGGTGCA
GGTGTTGCCATTGTGGCGTCCAACGGGAATCTTGTGTACCCTGTGCAGGTTACGAACAAA
AAGAAGCAAGTTTTTTCCAAGATCTTCTACTCGGAAGACGAGGGCAAGACGTGGAAGTTT
GGGAAGGGTAGGAGCGCTTTTGGCTGCTCTGAACCTGTGGCCCTTGAGTGGGAGGGGAAG
CTCATCATAAACACTCGAGTTGACTATCGCCGCCGTCTGGTGTACGAGTCCAGTGACATG
GGGAATTCGTGGCTGGAGGCTGTCGGCACGCTCTCACGTGTGTGGGGCCCCTCACCAAAA
TCGAACCAGCCCGGCAGTCAGAGCAGCTTCACTGCCGTGACCATCGAGGGAATGCGTGTT
ATGCTCTTCACACACCCGCTGAATTTTAAGGGAAGGTGGCTGCGCGACCGACTGAACCTC
TGGCTGACGGATAACCAGCGCATTTATAACGTTGGGCAAGTATCCATTGGTGATGAAAAT
TCCGCCTACAGCTCCGTCCTGTACAAGGATGATAAGCTGTACTGTTTGCATGAGATCAAC
AGTAACGAGGTGTACAGCCTTGTTTTTGCGCGCCTGGTTGGCGAGCTACGGATCATTAAA
TCAGTGCTGCAGTCCTGGAAGAATTGGGACAGCCACCTGTCCAGCATTTGCACCCCTGCT
GATCCAGCCGCTTCGTCGTCAGAGCGTGGTTGTGGTCCCGCTGTCACCACGGTTGGTCTT
GTTGGCTTTTTGTCGCACAGTGCCACCAAAACCGAATGGGAGGATGCGTACCGCTGCGTG
AACGCAAGCACGGCAAATGCGGAGAGGGTTCCGAACGGTTTGAAGTTTGCGGGGGTTGGC
GGAGGGGCGCTTTGGCCGGTGAGCCAGCAGGGGCAGAATCAACGGTATCGCTTTGCAAAC
CACGCGTTCACCGTGGTGGCGTCGGTGACGATTCACGAGGTTCCGAGCGTCGCGAGTCCT
TTGCTGGGTGCGAGCCTGGACTCTTCTGGTGGCAAAAAACTCCTGGGGCTCTCGTACGAC
GAGAGGCACCAGTGGCAGCCAATATACGGATCAACGCCGGTGACGCCGACCGGATCGTGG
GAGATGGGTAAGAGGTACCACGTGGTTCTTACGATGGCGAATAAAATTGGCTCCGAGTAC
ATTGATGGAGAACCTCTGGAGGGTTCAGGGCAGACCGTTGTGCCAGACGAGAGGACGCCT
GACATCTCCCACTTCTACGTTGGCGGGTATAAAAGGAGTGATATGCCAACCATAAGCCAC
GTGACGGTGAATAATGTTCTTCTTTACAACCGTCAGCTGAATGCCGAGGAGATCAGGACC
TTGTTCTTGAGCCAGGACCTGATTGGCACGGAAGCACACATGGACAGCAGCAGCGACACG
AGTGCCTGA

# Drug_Target_1_General_Function:
Involved in exo-alpha-sialidase activity

# Drug_Target_1_General_References:
12419220	Buschiazzo A, Amaya MF, Cremona ML, Frasch AC, Alzari PM: The crystal structure and mode of action of trans-sialidase, a key enzyme in Trypanosoma cruzi pathogenesis. Mol Cell. 2002 Oct;10(4):757-68.
7935611	Campetella OE, Uttaro AD, Parodi AJ, Frasch AC: A recombinant Trypanosoma cruzi trans-sialidase lacking the amino acid repeats retains the enzymatic activity. Mol Biochem Parasitol. 1994 Apr;64(2):337-40.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
4335

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
70594

# Drug_Target_1_Name:
Trans-sialidase

# Drug_Target_1_Number_of_Residues:
642

# Drug_Target_1_PDB_ID:
1S0K

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF02012	BNR

# Drug_Target_1_Protein_Sequence:
>Trans-sialidase
MLAPGSSRVELFKRQSSKVPFEKDGKVTERVVHSFRLPALVNVDGVMVAIADARYETSND
NSLIDTVAKYSVDDGETWETQIAIKNSRASSVSRVVDPTVIVKGNKLYVLVGSYNSSRSY
WTSHGDARDWDILLAVGEVTKSTAGGKITASIKWGSPVSLKEFFPAEMEGMHTNQFLGGA
GVAIVASNGNLVYPVQVTNKKKQVFSKIFYSEDEGKTWKFGKGRSAFGCSEPVALEWEGK
LIINTRVDYRRRLVYESSDMGNSWLEAVGTLSRVWGPSPKSNQPGSQSSFTAVTIEGMRV
MLFTHPLNFKGRWLRDRLNLWLTDNQRIYNVGQVSIGDENSAYSSVLYKDDKLYCLHEIN
SNEVYSLVFARLVGELRIIKSVLQSWKNWDSHLSSICTPADPAASSSERGCGPAVTTVGL
VGFLSHSATKTEWEDAYRCVNASTANAERVPNGLKFAGVGGGALWPVSQQGQNQRYRFAN
HAFTVVASVTIHEVPSVASPLLGASLDSSGGKKLLGLSYDERHQWQPIYGSTPVTPTGSW
EMGKRYHVVLTMANKIGSEYIDGEPLEGSGQTVVPDERTPDISHFYVGGYKRSDMPTISH
VTVNNVLLYNRQLNAEEIRTLFLSQDLIGTEAHMDSSSDTSA

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Not Available

# Drug_Target_1_SwissProt_ID:
Q26966

# Drug_Target_1_SwissProt_Name:
Q26966_TRYCR

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
7.42

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB01768
